Shijun Deng is a postdoctoral researcher based in Boston with a decade of experience probing the molecular underpinnings of chronic metabolic diseases, specializing in hepatic cholesterol metabolism. At Harvard since 2020, he combines mechanistic lipid biology with translational perspectives aimed at atherosclerotic cardiovascular disease. His PhD from the University of Alberta focused on cholesterol metabolism and atherosclerosis, building deep expertise in pathways that link liver biology to systemic metabolic risk. Trained in biological sciences at Queen’s University Belfast, he brings a strong experimental foundation and rigorous analytical approach to complex metabolic questions. Colleagues describe him as methodical and hypothesis-driven, with a knack for connecting cellular lipid handling to clinically relevant outcomes. He is particularly interested in how subtle alterations in hepatic cholesterol flux can drive disease progression and therapeutic opportunities.
9 years of coding experience
Ph.D, cholesterol metabolism and atherosclerotic cardiovascular diseases, A, Ph.D, cholesterol metabolism and atherosclerotic cardiovascular diseases, A at University of Alberta
Master of Philosophy (MPhil), Biological sciences, Master of Philosophy (MPhil), Biological sciences at Queen's University Belfast
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.
Request Free Trial
Shijun Deng - Postdoctoral Researcher at Harvard University